Relapsing membranous nephropathy. Response to therapy of relapses compared to that of the original disease

American Journal of Nephrology

Volumn 19, Issue 4, 1999, Pages 474-479

  Suki, Wadi N ^a   Trimarchi, Hernan ^a   Frommer, J Pedro ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Azathioprine; Chlorambucil; Cyclophosphamide; End stage renal disease; Nephrotic syndrome; Prednisone; Proteinuria; Relapsing membranous nephropathy

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; STEROID;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; KIDNEY FUNCTION; MEMBRANOUS GLOMERULONEPHRITIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RELAPSE; REMISSION; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREDNISONE; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032809308     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013501     Document Type: Article

References (19)

1. MacTier R, Boulton Jones JM, Payton CD, MyLay A: The natural history of membranous nephropathy in the west of Scotland. Q J Med NS 1986;60:793-802.
2. Donadio JV Jr, Torres VE, Velosa JA, Wagoner RD, Holley KE, Okamura M, Ilstrup DM, Chu CP: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 1988;33:708-715.
3. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasqualli S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, Bizarri D, Banfi G: A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995;48: 1600-1604.
4. Jindal K, West M, Bear R, Goldstein M: Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am J Kidney Dis 1992;19:61-67.
5. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill D, Clark W, Morrin P, Lavoie S: A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 1995;47:1130-1135.
6. Schiepatti A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993;329:85-89.
7. Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C: Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria. Nephrol Dial Transplant 1989;4:525-529.
8. Hogan SL, Muller KE, Jennette JC, Falk RJ: A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 1995;25:862-875.
9. Suki WN, Chavez A: Membranous nephropathy: Response to steroids and immunosuppression. Am J Nephrol 1981;1:11-16.
10. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, Bizarri D, Banfi G: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous glomerulonephritis. Ann Intern Med 1994;114:725-730.
11. Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S: A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989;320:210-215.
12. Cameron JS, Healy MJ, Adu D: The Medical Research Council trial of short-term, high dose, alternate day prednisolone in idiopathic membranous nephropathy with a nephrotic syndrome in adults. Q J Med 1990;74:133-139.
13. Bolton W, Atuk N, Sturgill B, Westervelt FB Jr: Therapy of the idiopathic nephrotic syndrome with alternate day steroids. Am J Med 1977;62: 60-66.
14. Collaborative Study of the Adult Nephrotic Syndrome: A controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 1979;301: 1301-1307.
15. Williams PS, Fass G, Bone JM: Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med NS 1988;67:343-354.
16. Reichert L, Koene R, Wetzels J: Prognostic factors in idiopathic membranous nephropathy. Am J Kidney Dis 1998;31:1-11.
17. Bruns F, Adler S, Fraley D, Segel D: Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone. Ann Intern Med 1991;114:725-730.
18. Manos J, Short CD, Acheson EJ, Dyer P, Lawler W, Mallick NP, Williams G: Relapsing idiopathic membranous nephropathy. Clin Nephrol 1982;18:286-290.
19. Tornroth T, Honaken E, Pettersson E: The evolution of membranous glomerulonephritis reconsidered: New insights from a study on relapsing disease. Clin Nephrol 1987;28:107-117.